febuxostat has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Naim, AB; Abdel-Rahman, HM; Abo-Youssef, AM; Afify, H; Allam, S; Azouz, AA | 1 |
| Abdel-Aziz, AM; Ali, AI; Gamal El-Tahawy, NF; Ibrahim, YF; Mohammed, MM; Salah Abdel Haleem, MA | 1 |
2 other study(ies) available for febuxostat and Adenoma, Prostatic
| Article | Year |
|---|---|
Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Topics: Androgens; Animals; Febuxostat; Gene Expression Regulation, Neoplastic; Gout Suppressants; Janus Kinase 1; Male; Prostatic Hyperplasia; Rats; Rats, Wistar; STAT3 Transcription Factor; Testosterone | 2020 |
Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Febuxostat; Male; Nitric Oxide Synthase Type II; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone Propionate; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |